Advertisement
Screener

electroCore, Inc. (ECOR) Proceeds from Other Equity

2.8 / 5 stars · 68/120 Roast Me

electroCore, Inc. Proceeds from Other Equity

electroCore, Inc. (ECOR) reported Proceeds from Other Equity of $217.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.

Financial Statements › Cash Flow › Financing Activities

us-gaap:ProceedsFromOtherEquity · last filed 2026-05-06

  • electroCore, Inc. proceeds from other equity for the quarter ending 2025-12-31 was $0.00.
  • electroCore, Inc. proceeds from other equity for the quarter ending 2025-09-30 was $0.00.
  • electroCore, Inc. proceeds from other equity for the quarter ending 2025-06-30 was $0.00.
  • electroCore, Inc. proceeds from other equity for the quarter ending 2025-03-31 was $217.00K.
  • electroCore, Inc. proceeds from other equity for fiscal 2025 was $217.00K, a 97.39% decline from fiscal 2024.
  • electroCore, Inc. proceeds from other equity for fiscal 2024 was $8.30M, a 1.92% increase from fiscal 2023.
  • electroCore, Inc. proceeds from other equity for fiscal 2023 was $8.14M.
  • electroCore, Inc. proceeds from other equity for fiscal 2021 was $25.68M, a 46.84% increase from fiscal 2020.
Period endProceeds from Other Equity 3 monthProceeds from Other Equity 6 monthProceeds from Other Equity 9 monthProceeds from Other Equity 12 monthProceeds from Other Equity 12 month as first filed
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19
$0.00
derived: sum of 2 quarters · filed 2026-03-19
$0.00
derived: sum of 3 quarters · filed 2026-03-19
$217.00K
10-K · filed 2026-03-19
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$0.00
derived: sum of 2 quarters · filed 2025-11-05
$217.00K
10-Q · filed 2025-11-05
$217.00K
derived: sum of 4 quarters · filed 2026-05-06
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$217.00K
10-Q · filed 2025-08-06
$217.00K
derived: sum of 3 quarters · filed 2026-05-06
$217.00K
derived: sum of 4 quarters · filed 2026-05-06
2025-03-31$217.00K
10-Q · filed 2026-05-06
$217.00K
derived: sum of 2 quarters · filed 2026-05-06
$217.00K
derived: sum of 3 quarters · filed 2026-05-06
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19
$0.00
derived: sum of 2 quarters · filed 2026-03-19
$8.30M
10-K · filed 2026-03-19
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$8.30M
10-Q · filed 2025-11-05
2024-06-30$8.30M
10-Q · filed 2025-08-06
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12
$8.14M
10-K · filed 2025-03-12
2023-09-30$8.14M
10-Q · filed 2024-11-13
2021-12-31$25.68M
10-K · filed 2023-03-08
$25.68M
10-K · filed 2022-03-10
2020-12-31$17.49M
10-K · filed 2022-03-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Neuraxis, INC (NRXS)United States$0.097B
Nexalin Technology, Inc. (NXL)United States$0.094B
Vivani Medical, Inc. (VANI)United States$0.111B
Streamex Corp. (STEX)United States$0.089B-0.19
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
EDAP TMS SA (FOCL)$0.171B
IRIDEX CORP (IRIX)United States$0.011B